Olivier Jarry biography
Olivier Jarry serves as Senior Vice President - Strategy and Business Development of the Company. Mr. Jarry has served on our Advisory Board and as a Strategic Advisory consultant since 2017. Between 2015 and 2016, Mr. Jarry served as Senior Vice-President of the Consumer Sector and Officer at Intrexon Corp. (NYSE:XON), a biotechnology company focused on engineering biological systems to enable DNA-based control over the function and output of living cells. Prior to Intrexon, from 2011 to 2012, Mr. Jarry served as the Head of Strategy, Operations and Market Access, focusing on Emerging Markets, for Bristol-Myers Squibb (NYSE:BMY), where he oversaw the product launch and growth of innovative medicines relating to oncology, virology, rheumatology, cardiovascular, and diabetes. Prior to that, between 2009 and 2010, Mr. Jarry served as the Global Business Unit Head of Bayer Diabetes Care, a division of Bayer HealthCare Pharmaceuticals LLC. Prior to his time at Bayer HealthCare, from 2001 to 2009, Mr. Jarry served in several leadership roles at Novartis International AG (NYSE:NVS), including working as Global Division Head of Strategy, Business Development & Licensing at Novartis Headquarters in Switzerland, Senior Vice President and Region Head for Latin America and for Asia-Pacific for Novartis’ Consumer Health Division, Head of India Rural Business and Head of Western/Eastern Europe, Russia, CIS - Vaccines division. Mr. Jarry holds a M.Sc. degree from Ecole Centrale de Paris, a MEng. degree from Délégation Générale pour l’Armement, and a Trium Executive MBA degree jointly awarded by NYU Stern School of Business, London School of Economics and Political Science and Hautes Études Commerciales Paris.
What is the salary of Olivier Jarry?
As the Senior Vice President - Strategy and Business Development of DarioHealth Corp, the total compensation of Olivier Jarry at DarioHealth Corp is $280,945. There are 5 executives at DarioHealth Corp getting paid more, with Erez Raphael having the highest compensation of $1,382,200.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
How old is Olivier Jarry?
Olivier Jarry is 58, he's been the Senior Vice President - Strategy and Business Development of DarioHealth Corp since 2020. There are 5 older and 11 younger executives at DarioHealth Corp. The oldest executive at DarioHealth Corp is Richard Stone, 77, who is the Independent Director.
What's Olivier Jarry's mailing address?
Olivier's mailing address filed with the SEC is 8 HATOKHEN STREET, , CAESAREA INDUSTRIAL PARK, L3, 3088900.
Insiders trading at DarioHealth Corp
Over the last 9 years, insiders at DarioHealth Corp have traded over $4,057,564 worth of DarioHealth Corp stock and bought 2,163,162 units worth $794,618 . The most active insiders traders include Erez Raphael, Adam K Stern és Yoav Shaked. On average, DarioHealth Corp executives and independent directors trade stock every 33 days with the average trade being worth of $20,360. The most recent stock trade was executed by Steven Charles Nelson on 5 September 2024, trading 15,000 units of DRIO stock currently worth $12,300.
What does DarioHealth Corp do?
DarioHealth Corp. (NASDAQ:DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition digital therapeutics platform.
What does DarioHealth Corp's logo look like?
DarioHealth Corp executives and stock owners
DarioHealth Corp executives and other stock owners filed with the SEC include:
-
Erez Raphael,
Chief Executive Officer, Director -
Erez Raphael,
CEO & Director -
Richard A. Anderson,
Pres & GM of North America -
Dror Bacher,
Chief Operating Officer -
Zvi Ben-David,
Chief Financial Officer, Treasurer, Secretary -
Olivier Jarry,
Senior Vice President - Strategy and Business Development -
Dror Bacher,
Chief Operating Officer -
Zvi Ben David,
CFO, Treasurer & Sec. -
Richard Stone,
Independent Director -
Dennis McGrath,
Independent Director -
Hila Karah,
Independent Director -
Dennis Matheis,
Director -
Omar Manejwala,
Chief Medical Officer -
Barbara Stark,
Senior Vice President, Head of Managed Markets -
Adam Stern,
Director -
Yadin Shemmer,
Independent Director -
Richard Anderson,
President, General Manager - North America -
Allen Kamer,
Independent Director -
Yoav Shaked,
Independent Chairman of the Board -
Limor Drezner,
VP HR & Chief of Staff -
Josh Fischer,
Sr. VP of Operations & Compliance -
Yinon Amir,
Head of Software Innovation -
Jean Christophe Muyl,
Head of Commercialization North America -
Suzanne Bedell,
VP of Marketing -
Claudia Levi,
Content & Communications Mang. -
Dov Oppenheim,
Co-Founder & Production Chief -
Olivier R. Jarry,
Sr. VP of Strategy & Bus. Devel. -
Hod Rami Yehudiha,
Director -
Glen Moller,
Director -
Yalon Farhi,
Director -
Malcolm Hoenlein,
Director -
Ori Zanco,
Director -
Yossi Bahagon,
Director -
Shmuel Farhi,
10% owner -
Yossef Balucka,
CEO and President -
Oded Cohen,
GM MSK -
Jon H. Kaplan,
Director -
Tomer Ben Kiki,
Chief Operating Officer -
Steven Charles Nelson,
Chief Commercial Officer